Impaired baroreflex control of renal sympathetic nerve activity in type 1 diabetic mice (OVE26)

Neuroscience

Volumn 161, Issue 1, 2009, Pages 78-85

  Gu, H ^a   Zhang, Z H ^b   Epstein, P N ^c   Li, L ^a   Harden, S W ^a   Wurster, R D ^d   Cheng, Z J ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of Louisville School of Medicine   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

baroreceptor; baroreflex; diabetes mellitus; nephropathy; neuropathy; sympathetic

Indexed keywords

NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NEUROPATHY; BRAIN DEPTH STIMULATION; CHOLINERGIC TRANSMISSION; CHRONIC DISEASE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MEAN ARTERIAL PRESSURE; MOUSE; NERVE CONDUCTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; TRANSGENIC MOUSE;

ANIMALS; AORTA; BAROREFLEX; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; ELECTRIC STIMULATION; KIDNEY; MICE; MICE, TRANSGENIC; NITROPRUSSIDE; PHENYLEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 67349202493     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.02.083     Document Type: Article

References (55)

1. Bell D.S. Dead in bed syndrome-a hypothesis. Diabetes Obes Metab 8 (2006) 261-263
2. Cameron N.E., Cotter M.A., and Low P.A. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261 (1991) E1-E8
3. Caviezel F., Picotti G.B., Margonato A., Slaviero G., Galva M.D., Camagna P., Bondiolotti G.P., Carruba M.O., and Pozza G. Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathetic stimulation. Diabetologia 23 (1982) 19-23
4. Chang K.S., and Lund D.D. Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats. J Mol Cell Cardiol 18 (1986) 617-624
5. Chapleau M.W., and Abboud F.M. The baroreceptor reflex: novel methods and mechanisms. In: Dun N.J., Machado B.H., and Pilowsky P.M. (Eds). Neural Mechanisms of Cardiovascular Regulation (2004), Kluwer Academic, Norwell 1-20
6. Chapleau M.W., Li Z., Meyrelles S.S., Ma X., and Abboud F.M. Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci 940 (2001) 1-19
7. Dall'Ago P., D'Agord Schaan B., da Silva V.O.K., Werner J., da Silva Soares P.P., de Angelis K., and Irigoyen M.C. Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton Neurosci 131 (2007) 28-35
8. Dalla Pozza R., Bechtold S., Bonfig W., Putzker S., Kozlik-Feldmann R., Schwarz H.P., and Netz H. Impaired short-term blood pressure regulation and autonomic dysbalance in children with type 1 diabetes mellitus. Diabetologia 50 (2007) 2417-2423
9. De Angelis K., Schaan B.D., Maeda C.Y., Dall'Ago P., Wichi R.B., and Irigoyen M.C. Cardiovascular control in experimental diabetes. Braz J Med Biol Res 35 (2002) 1091-1100
10. Eckberg D.L., Harkins S.W., Fritsch J.M., Musgrave G.E., and Gardner D.F. Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Invest 78 (1986) 366-374
11. Epstein P.N., Overbeek P.A., and Means A.R. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58 (1989) 1067-1073
12. Greene D.A., De Jesus Jr. P.V., and Winegrad A.I. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 55 (1975) 1326-1336
13. Greene D.A., and Lattimer S.A. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72 (1983) 1058-1063
14. Gross V., Tank J., Partke H.J., Plehm R., Diedrich A., da Costa Goncalves A.C., Luft F.C., and Jordan J. Cardiovascular autonomic regulation in non-obese diabetic (nod) mice. Auton Neurosci 138 (2008) 108-113
15. Gu H., Epstein P.N., Li L., Wurster R.D., and Cheng Z.J. Functional changes in baroreceptor afferent, central and efferent components of the baroreflex circuitry in type 1 diabetic mice (OVE26). Neuroscience 152 (2008) 741-752
16. Hilsted J., Parving H.H., Christensen N.J., Benn J., and Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 68 (1981) 1427-1434
17. Hilsted J. Decreased sympathetic vasomotor tone in diabetic orthostatic hypotension. Diabetes 28 (1979) 970-973
18. Hirai F.E., Moss S.E., Klein B.E., and Klein R. Postural blood pressure changes and associated factors in long-term type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. J Diabetes Complications 23 (2009) 83-88
19. Huang C., Li L., Shang X., Epstein P.N., and Cheng Z. Structural remodeling of nucleus ambiguus (NA) projections to cardiac ganglia in transgenic type 1 diabetic mice (OVE26). FASEB J 22 (2008) 2 950
20. Huang C., Li L., Yan B., Epstein P.N., and Cheng Z. Structural remodeling of baroreceptor afferent innervation of aortic arch in transgenic type 1 diabetic mice (OVE 26). FASEB J 22 (2008) 3 950
21. Huang W.C., Fang T.C., and Cheng J.T. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension 32 (1998) 249-254
22. Inada A., Kanamori H., Arai H., Akashi T., Araki M., Weir G.C., and Fukatsu A. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J Cell Physiol 215 (2008) 383-391
23. Jarrett R.J. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 5 (1989) 547-558
24. Kent B.B., Drane J.W., Blumenstein B., and Manning J.W. A mathematical model to assess changes in the baroreceptor reflex. Cardiology 57 (1972) 295-310
25. Koitka A., and Tikellis C. Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy. Sci World J 8 (2008) 434-445
26. Lawrence I.G., Weston P.J., Bennett M.A., McNally P.G., Burden A.C., and Thurston H. Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus?. Diabet Med 14 (1997) 82-85
27. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., and Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51 (2002) 174-181
28. Ma X., Abboud F.M., and Chapleau M.W. Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol 283 (2002) R1033-R1040
29. Maliszewska-Scislo M., Scislo T.J., and Rossi N.F. Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats. Am J Physiol Heart Circ Physiol 284 (2003) H1601-H1611
30. McDowell T.S., Hajduczok G., Abboud F.M., and Chapleau M.W. Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am J Physiol 266 (1994) H244-H249
31. McNally P.G., Lawrence I.G., Panerai R.B., Weston P.J., and Thurston H. Sudden death in type 1 diabetes. Diabetes Obes Metab 1 (1999) 151-158
32. Morley J.E. Falls-where do we stand?. Mo Med 104 (2007) 63-67
33. Pabbidi R.M., Cao D.S., Parihar A., Pauza M.E., and Premkumar L.S. Direct role of streptozotocin in inducing thermal hyperalgesia by enhanced expression of transient receptor potential vanilloid 1 in sensory neurons. Mol Pharmacol 73 (2008) 995-1004
34. Patel K.P., and Zhang P.L. Reduced renal sympathoinhibition in response to acute volume expansion in diabetic rats. Am J Physiol 267 (1994) R372-R379
35. Patel K.P., and Zhang P.L. Baroreflex function in streptozotocin (STZ) induced diabetic rats. Diabetes Res Clin Pract 27 (1995) 1-9
36. Perin P.C., Maule S., and Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 23 (2001) 45-55
37. Sanya E.O., Brown C.M., Dutsch M., Zikeli U., Neundorfer B., and Hilz M.J. Impaired cardiovagal and vasomotor responses to baroreceptor stimulation in type II diabetes mellitus. Eur J Clin Invest 33 (2003) 582-588
38. Seagard J.L., Elegbe E.O., Hopp F.A., Bosnjak Z.J., von Colditz J.H., Kalbfleisch J.H., and Kampine J.P. Effects of isoflurane on the baroreceptor reflex. Anesthesiology 59 (1983) 511-520
39. Shen X., Ye G., Metreveli N.S., and Epstein P.N. Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol Med 112 (2005) 379-388
40. Shoham S., Bejar C., Kovalev E., and Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184 (2003) 1043-1052
41. Song Y., Du Y., Prabhu S.D., and Epstein P.N. Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility. Rev Diabet Stud 4 (2007) 159-168
42. Weck M. Treatment of hypertension in patients with diabetes mellitus: relevance of sympathovagal balance and renal function. Clin Res Cardiol 96 (2007) 707-718
43. Weston P.J., and Gill G.V. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus?. The "dead in bed" syndrome revisited. Diabet Med 16 (1999) 626-631
44. Weston P.J., James M.A., Panerai R., McNally P.G., Potters J.F., Thurston H., and Swales J.D. Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic function in patients with insulin-dependent diabetes mellitus. Clin Sci 91 (1996) 59-64
45. Weston P.J., Panerai R.B., McCullough A., McNally P.G., James M.A., Potter J.F., Thurston H., and Swales J.D. Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia 39 (1996) 1385-1391
46. Witte D.R., Tesfaye S., Chaturvedi N., Eaton S.E., Kempler P., and Fuller J.H. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 48 (2005) 164-171
47. Wold L.E., and Ren J. Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun 318 (2004) 1066-1071
48. Wu K.K., and Huan Y. Diabetic atherosclerosis mouse models. Atherosclerosis 191 (2007) 241-249
49. Ye G., Donthi R.V., Metreveli N.S., and Epstein P.N. Overexpression of hexokinase protects hypoxic and diabetic cardiomyocytes by increasing ATP generation. Cardiovasc Toxicol 5 (2005) 293-300
50. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., and Epstein P.N. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53 (2004) 1336-1343
51. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
52. Zaruba R.A., Epstein P.N., and Carr P.A. Hyperglycemia alters enzyme activity and cell number in spinal sensory ganglia. J Brachial Plex Peripher Nerve Inj 2 (2007) 11
53. Zhang Z.H., and Felder R.B. Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat. Am J Physiol Regul Integr Comp Physiol 286 (2004) R303-R310
54. Zheng S., Carlson E.C., Yang L., Kralik P.M., Huang Y., and Epstein P.N. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J Am Soc Nephrol 19 (2008) 2077-2085
55. Zheng S., Noonan W.T., Metreveli N.S., Coventry S., Kralik P.M., Carlson E.C., and Epstein P.N. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53 (2004) 3248-3257